Purchase Order 75N98026P01120

This $89,250.00 firm-fixed price purchase order was awarded to Cantata Bio LLC, a small business in Santa Cruz, California, by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services. The award is for Cantata Bio's CANTATA MICRO-C LIBRARY PREPARATION services, which involve genomic library preparation and sequencing capabilities applicable to biomedical research. This award does not have a set-aside designation. Cantata Bio has previously...

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $24,158.08 on October 19, 2017, with an ultimate completion date of November 19, 2018. Performance occurs at Bethesda, Maryland. The order is firm fixed price with no set-aside designation. Specific requirements are not detailed in the source material.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $51,233.44 on March 18, 2016, covering an 11-month service maintenance agreement for HiScan, MiSeq, and CBOT equipment. Place of performance is Bethesda, Maryland. The order carries firm fixed-price pricing with an ultimate completion date of April 24, 2021. The procurement funded de-obligation of expiring FY2016 lines.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. valued at $16,362.77 on February 26, 2020, for a service agreement with a firm fixed price. Work is performed in Bethesda, Maryland, with an ultimate completion date of May 31, 2020. The order procures sequencing-related services or equipment from Illumina's portfolio of genomic analysis technologies and associated support.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $12,130.80 on June 11, 2020, with ultimate completion on June 14, 2021. The order covers a maintenance agreement on a firm fixed price basis. Work is performed in San Diego, California. No set-aside was used.</p>

<p>The National Cancer Institute issued a $5,100.20 delivery order to Illumina, Inc. on August 24, 2017, with an ultimate completion date of September 25, 2017.</p> <p>Place of performance is Bethesda, MD 20892. The order is priced on a firm fixed-price basis with no set-aside designation. The source does not specify the parent vehicle or the specific goods or services being delivered under this order.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. valued at $12,560.00 on February 22, 2021, for a service agreement with a firm fixed price structure and no set-aside designation. Performance is located in Bethesda, Maryland, with an ultimate completion date of April 30, 2021.</p>

<p>The National Cancer Institute issued a $17,792.10 delivery order to Illumina, Inc. on January 13, 2020, for reagents and consumables.</p> <p>Place of performance is Bethesda, MD 20892. Ultimate completion date is February 12, 2020. The order is firm fixed price with no set-aside designation.</p>

The National Cancer Institute awarded a purchase order to Illumina, Inc. for maintenance and service of government-owned Illumina sequencing platforms and ancillary equipment, with a ceiling value of $1,042,524.31 and an award date of May 8, 2026. Work is performed at Bethesda, Maryland. The order covers on-site maintenance services for NextSeq 2000, NextSeq 550Dx, iScan, and related devices in accordance with Original Equipment Manufacturer standards, including replacement parts and software...

<p>The National Cancer Institute issued a $13,402.80 delivery order to Illumina, Inc. on March 26, 2019, for catalog item 20024907NSQ 500/550 HI OUTPUT KT V2.5 (150 cycles). Place of performance is San Diego, CA 92122. The order is firm fixed price with an ultimate completion date of April 25, 2019. No set-aside was used.</p>